Endpoints and assessments
Tumor
SECONDARY, TUMOR
Tumor response was assessed every 9 weeks for 3 times and every 12 weeks thereafter. The primary endpoint was ORR assessed by IRC based on RECIST v1.1. The secondary endpoints were ORR assessed by investigators based on iRECIST [